Kato Y - Search Results

1

Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice.

Jin M, Shimada T, Yokogawa K, Nomura M, Ishizaki J, Piao Y, Kato Y, Tsuji A, Miyamoto K. Jin M, et al. Among authors: kato y. Biochem Pharmacol. 2006 Oct 16;72(8):1042-50. doi: 10.1016/j.bcp.2006.07.020. Epub 2006 Aug 30. Biochem Pharmacol. 2006. PMID: 16939683 Free article.

2

Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines.

Li Q, Sai Y, Kato Y, Tamai I, Tsuji A. Li Q, et al. Among authors: kato y. Pharm Res. 2003 Aug;20(8):1119-24. doi: 10.1023/a:1025076326061. Pharm Res. 2003. PMID: 12948007

3

Transporter-mediated renal handling of nafamostat mesilate.

Li Q, Sai Y, Kato Y, Muraoka H, Tamai I, Tsuji A. Li Q, et al. Among authors: kato y. J Pharm Sci. 2004 Feb;93(2):262-72. doi: 10.1002/jps.10534. J Pharm Sci. 2004. PMID: 14705184

4

Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice.

Sasabe H, Kato Y, Suzuki T, Itose M, Miyamoto G, Sugiyama Y. Sasabe H, et al. Among authors: kato y. J Pharmacol Exp Ther. 2004 Aug;310(2):648-55. doi: 10.1124/jpet.104.065201. Epub 2004 May 6. J Pharmacol Exp Ther. 2004. PMID: 15131241

5

Characterization of renal excretion mechanism for a novel diuretic, M17055, in rats.

Nishimura T, Kato Y, Sai Y, Ogihara T, Tsuji A. Nishimura T, et al. Among authors: kato y. J Pharm Sci. 2004 Oct;93(10):2558-66. doi: 10.1002/jps.20165. J Pharm Sci. 2004. PMID: 15349965

6

Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population.

Kawasaki Y, Kato Y, Sai Y, Tsuji A. Kawasaki Y, et al. Among authors: kato y. J Pharm Sci. 2004 Dec;93(12):2920-6. doi: 10.1002/jps.20190. J Pharm Sci. 2004. PMID: 15459889

7

Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.

Inano A, Sai Y, Kato Y, Tamai I, Ishiguro M, Tsuji A. Inano A, et al. Among authors: kato y. Drug Metab Pharmacokinet. 2004 Jun;19(3):180-9. doi: 10.2133/dmpk.19.180. Drug Metab Pharmacokinet. 2004. PMID: 15499185 Free article.

8

PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2.

Kato Y, Sai Y, Yoshida K, Watanabe C, Hirata T, Tsuji A. Kato Y, et al. Mol Pharmacol. 2005 Mar;67(3):734-43. doi: 10.1124/mol.104.002212. Epub 2004 Nov 2. Mol Pharmacol. 2005. PMID: 15523054

9

Screening of the interaction between xenobiotic transporters and PDZ proteins.

Kato Y, Yoshida K, Watanabe C, Sai Y, Tsuji A. Kato Y, et al. Pharm Res. 2004 Oct;21(10):1886-94. doi: 10.1023/b:pham.0000045244.83999.43. Pharm Res. 2004. PMID: 15553237

10

Involvement of multiple transport systems in the disposition of an active metabolite of a prodrug-type new quinolone antibiotic, prulifloxacin.

Yagi Y, Shibutani S, Hodoshima N, Ishiwata K, Okudaira N, Li Q, Sai Y, Kato Y, Tsuji A. Yagi Y, et al. Among authors: kato y. Drug Metab Pharmacokinet. 2003;18(6):381-9. doi: 10.2133/dmpk.18.381. Drug Metab Pharmacokinet. 2003. PMID: 15618759 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,732 results

Search Page

Filters